49 - Outcome of Lower-Risk Patients with Myelodysplastic Syndromes without 5Q Deletion after Failure of Erythropoiesis Stimulating Agents

Journal article

Peer reviewed

S. Park, J.F. Hamel, A. Toma, C. Kelaidi, S. Thepot, M. Campelo Diez, V. Santini, M. Sekeres, E. Balleari, J. Kaivers, …

Leukemia research, Vol.55, pp.S33-S33

2017-04

Metrics

3 Record Views

This output has contributed to the advancement of the following goals:

Source: InCites

Title: 49 - Outcome of Lower-Risk Patients with Myelodysplastic Syndromes without 5Q Deletion after Failure of Erythropoiesis Stimulating Agents
Creators: S. Park
J.F. Hamel
A. Toma
C. Kelaidi
S. Thepot
M. Campelo Diez
V. Santini
M. Sekeres
E. Balleari
J. Kaivers
K. Goetze
O. Beyne-Rauzy
A. Stamatoullas
I. Kotsianidis
R. Komrokji
D. Steensma
U. Germing
G. Sanz
F. Dreyfus
P. Fenaux
Publication Details: Leukemia research, Vol.55, pp.S33-S33
Publisher: Elsevier Ltd
Academic Unit: Miller School of Medicine; UMMG Dept of Medicine - Hematology/Oncology
Language: English
Resource Type: Journal article
Record Identifier: 991031785793602976